During the last session, Viridian Therapeutics Inc (NASDAQ:VRDN)’s traded shares were 0.77 million, with the beta value of the company hitting 0.47. At the end
In the last trading session, 1.45 million Viridian Therapeutics Inc (NASDAQ:VRDN) shares changed hands as the company’s beta touched 0.43. With the company’s per share
During the last session, Viridian Therapeutics Inc (NASDAQ:VRDN)’s traded shares were 0.66 million, with the beta value of the company hitting 0.47. At the end
In the last trading session, 1.19 million shares of the Viridian Therapeutics Inc (NASDAQ:VRDN) were traded, and its beta was 0.47. Most recently the company’s
In last trading session, Viridian Therapeutics Inc (NASDAQ:VRDN) saw 0.52 million shares changing hands with its beta currently measuring 0.62. Company’s recent per share price
As the biotechnology business prepares to take part in a significant event, shares of Viridian Therapeutics Inc. (Nasdaq: VRDN) were up 13.64% at $26.00 at
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne